Recombinant human growth hormone

This page covers all Recombinant human growth hormone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dimeric GH receptors on cell membranes, Dimeric GH receptors on cell membranes of target tissues, Growth hormone receptor.

Targets

Dimeric GH receptors on cell membranes · Dimeric GH receptors on cell membranes of target tissues · Growth hormone receptor · Growth hormone receptor (GHR)

Marketed (5)

• Omnitrope · Serono · 446
  Somatropin binds dimeric GH receptors on target cells, inducing intracellular signaling and GH-dependent protein synthesis including IGF-1.
• Omnitrope · Serono · Metabolic · 446
  Somatropin binds dimeric GH receptors on target cells, inducing intracellular signaling and GH-dependent protein synthesis including IGF-1.
• Nutropin AQ · Children's Mercy Hospital Kansas City · Endocrinology
  Nutropin AQ is a recombinant human growth hormone that binds to growth hormone receptors to stimulate growth and metabolic processes.
• Genotropin (somatropin) · Pfizer · Endocrinology
  Genotropin is a recombinant human growth hormone that binds to growth hormone receptors to stimulate growth, metabolism, and body composition changes.
• NGENLA (Somatrogon) · Pfizer · Hematology

Phase 3 pipeline (2)

• Genotonorm (Somatropin) · Pfizer · Endocrinology
  Somatropin is a recombinant human growth hormone that binds to growth hormone receptors to stimulate growth, metabolism, and body composition changes.
• Placebo and Saizen® · Merck KGaA, Darmstadt, Germany · Endocrinology
  Saizen® is a recombinant human growth hormone that replaces or supplements endogenous growth hormone to promote growth and metabolic effects.